Entity Public Float in USD of GT Biopharma, Inc. from Q3 2011 to Q2 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
GT Biopharma, Inc. quarterly Entity Public Float history and change rate from Q3 2011 to Q2 2024.
  • GT Biopharma, Inc. Entity Public Float for the quarter ending 30 Jun 2024 was $5.1M, a 55.7% decline year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

GT Biopharma, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.1M -$6.4M -55.7% 30 Jun 2024 10-K/A 14 Apr 2025
Q2 2023 $11.5M -$78.3M -87.2% 30 Jun 2023 10-K 26 Mar 2024
Q2 2022 $89.8M -$283M -75.9% 30 Jun 2022 10-K 30 Mar 2023
Q2 2021 $372M +$363M +4083% 30 Jun 2021 10-K 28 Mar 2022
Q2 2020 $8.9M +$1.7M +23.6% 30 Jun 2020 10-K 16 Apr 2021
Q2 2019 $7.2M -$33.2M -82.2% 30 Jun 2019 10-K 27 Mar 2020
Q2 2018 $40.4M +$37.9M +1516% 30 Jun 2018 10-K 29 Mar 2019
Q2 2017 $2.5M -$90.5M -97.3% 30 Jun 2017 10-K 01 Mar 2018
Q2 2016 $93M +$79.9M +610% 30 Jun 2016 10-K/A 28 Feb 2018
Q2 2015 $13.1M 30 Jun 2015 10-K/A 28 Feb 2018
Q4 2014 $2.9M 31 Dec 2014 10-K 31 Mar 2015
Q3 2014 $10.9M 23 Oct 2014 10-K 18 Nov 2014
Q2 2013 $0 30 Jun 2013 10-K 08 Jan 2015
Q1 2012 $269K 13 Apr 2012 10-K 16 Apr 2012
Q4 2011 $154M 21 Nov 2011 10-Q 21 Nov 2011
Q3 2011 $154M 15 Aug 2011 10-Q/A 12 Sep 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.